Advertisement
Screener

Affirm Holdings, Inc. (AFRM) Spending and interest coverage

Affirm Holdings, Inc. (AFRM) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 21.10%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months21.10%Share-based compensation / revenue. Period ending 2026-06-30.

$304.67M ÷ $1.44B × 100 ≈ 21.10%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue1.44B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation304.67M USDShare-based Payment Arrangement, Noncash Expense
Operating income416.98M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$1.44B$304.67M$416.98M(m)(m)21.10%(m)(m)
2026-03-31(m)$1.36B$302.99M$327.78M(m)(m)22.23%(m)(m)
2025-12-31(m)$1.30B$304.75M$230.96M(m)(m)23.42%(m)(m)
2025-09-30(m)$1.20B$313.05M$109.01M(m)(m)26.03%(m)(m)
2025-06-30(m)$1.11B$321.43M$-87.27M(m)(m)28.85%(m)(m)
2025-03-31(m)$1.03B$320.85M$-218.80M(m)(m)31.11%(m)(m)
2024-12-31(m)$953.81M$322.32M$-371.19M(m)(m)33.79%(m)(m)
2024-09-30(m)$878.40M$326.38M$-539.02M(m)(m)37.16%(m)(m)
2024-06-30(m)$826.01M$344.51M$-615.85M(m)(m)41.71%(m)(m)
2024-03-31(m)$777.48M$382.94M$-786.22M(m)(m)49.25%(m)(m)
2023-12-31(m)$731.00M$412.65M$-935.46M(m)(m)56.45%(m)(m)
2023-09-30(m)$666.51M$444.26M$-1.12B(m)(m)66.65%(m)(m)
2023-06-30(m)$626.94M$451.71M$-1.20B(m)(m)72.05%(m)(m)
2023-03-31(m)$601.17M$459.24M$-1.23B(m)(m)76.39%(m)(m)
2022-12-31(m)$596.92M$450.84M$-1.15B(m)(m)75.53%(m)(m)
2022-09-30(m)$587.42M$417.60M$-987.44M(m)(m)71.09%(m)(m)
2022-06-30(m)$559.21M$390.98M$-866.05M(m)(m)69.92%(m)(m)
2022-03-31(m)$517.43M$375.78M$-698.60M(m)(m)72.63%(m)(m)
2021-12-31(m)$485.01M$457.04M$-681.40M(m)(m)94.23%(m)(m)
2021-09-30(m)$441.82M$375.02M$-511.97M(m)(m)84.88%(m)(m)
2021-06-30(m)$429.40M$288.03M$-379.19M(m)(m)67.08%(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)$276.09M$29.63M$-107.79M(m)(m)10.73%(m)(m)
2020-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30(m)$140.27M$33.70M$-127.44M(m)(m)24.03%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.